Bode v. Los Angeles Doctors Hospital CA2/5

CourtCalifornia Court of Appeal
DecidedAugust 20, 2014
DocketB244502
StatusUnpublished

This text of Bode v. Los Angeles Doctors Hospital CA2/5 (Bode v. Los Angeles Doctors Hospital CA2/5) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bode v. Los Angeles Doctors Hospital CA2/5, (Cal. Ct. App. 2014).

Opinion

Filed 8/20/14 Bode v. Los Angeles Doctors Hospital CA2/5 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION FIVE

GEORGIA BODE, B244502

Plaintiff and Appellant, (Los Angeles County Super. Ct. No. BC428929) v.

LOS ANGELES DOCTORS HOSPITAL CORPORATION et al.,

Defendants and Appellants.

APPEAL from a judgment of the Superior Court of Los Angeles County, Elizabeth White, Judge. Reversed and remanded with directions. Fenton Nelson, Henry R. Fenton, Dennis E. Lee, Nicholas D. Jurkowitz, for Plaintiff and Appellant. Lewis Brisbois Bisgaard & Smith, Jeffry A. Miller, Matthew S. Pascale, Judith M. Tishkoff, Lann G. McIntyre, for Defendants and Appellants. ___________________ Plaintiff Georgia Bode, M.D., filed the instant action against defendants Pacific Health Corporation, Los Angeles Doctors Hospital Corporation, Los Angeles Doctors Corporation, and Medical Staff of Los Angeles Metropolitan Medical Center (collectively the Hospital) in connection with the suspension and nonrenewal of temporary staff privileges. The Hospital filed a motion for summary adjudication, which the trial court granted in part. After a jury trial awarding damages, Bode and the Hospital each appeal from the judgment. The Hospital contends the court should have granted summary adjudication on the issue of immunity, because the Hospital had immunity under the federal Health Care Quality Improvement Act of 1986 (HCQIA) (42 U.S.C. § 11101 et seq.) and immunity for noneconomic damages under Civil Code section 43.97. We conclude summary adjudication was properly denied on the issue of immunity under HCQIA, because ample evidence showed the Hospital failed to provide adequate notice and hearing required for protection under federal law. However, the court could not summarily adjudicate the issue against the Hospital in the manner it did. The judgment must be reversed and remanded for a proper determination of the issue of immunity under HCQIA. In addition, we find summary adjudication should have been granted in favor of the Hospital on the issue of immunity under Civil Code section 43.97, which precludes liability for damages other than economic and pecuniary damages. In her appeal, Bode contends triable issues of fact exist as to intentional infliction of emotional distress and punitive damages. We conclude summary adjudication of these claims was proper. Bode also appeals from a postjudgment order denying attorney fees under Business and Professions Code section 809.9.1 Because the judgment must be reversed for further proceedings, the ruling on the postjudgment motion for attorney fees is moot.

1All further statutory references are to the Business and Professions Code, unless otherwise stated.

2 FACTS AND PROCEDURAL BACKGROUND

Undisputed Facts

In 2002, the Hospital received conditional accreditation, in part because of inadequate monitoring of controlled substances. The Hospital implemented Sure-Med, which is a computer-operated drug dispensary system. To operate Sure-Med, a physician enters a password and other information to request drugs for a patient. After the patient’s procedure, the physician enters information about drugs used, returned to the Sure-Med system, or “wasted,” meaning disposed of in an authorized manner. A hospital staff member must witness and confirm the return of any drugs. The medication is deposited in a locked container in the machine and verified later. On January 1, 2003, Bode applied for membership on the Hospital’s medical staff. She began working as an anesthesiologist at the Hospital under temporary, but renewable, 90-day practice privileges pending action on her application. On January 21, 2003, the peer review subcommittee of the Hospital’s surgery department met to discuss documentation issues. The following day, chair of the surgery department, Dr. Dapo Popoola, sent Bode a letter listing six incidents concerning documentation: an anesthesia record on January 6, 2003, was incomplete, lacked her signature, and showed a portion of Duramorph was used, but no wastage was recorded; an anesthesia record on January 8, 2003, was incomplete, lacked her signature, and improperly documented wastage; two anesthesia records on January 13, 2003, were incomplete and lacked her signature; on January 16, 2003, she failed to document the strength of Fentanyl administered; and on January 18, 2003, she used a portion of Duramorph but did not record wastage. Popoola noted that the incidents deviated from the standard of care, hospital policy, and the accreditation standard for appropriately controlling the dispensing of medications. Popoola warned, “Any further occurrence[s] may result in disciplinary

3 action including suspension of privileges.” (Boldface omitted.) The Hospital’s records reflect Bode received additional training and resolved the documentation problems. The surgery department forwarded its conclusions and recommendations regarding the six incidents to the Medical Executive Committee (MEC). The MEC accepted the peer review report, noted the surgery department’s action, and accepted the surgery department’s decision not to place Bode on immediate suspension. On March 18, 2003, Bode withdrew three ampules of Fentanyl, two vials of Versed, and one ampule of Demerol from the Sure-Med system to administer to a surgery patient. The patient’s chart reflected that all of the Fentanyl and one vial of the Versed were administered. Bode entered her return of the Demerol and the remaining Versed vial in the Sure-Med system. Nurse Zoila Vargas witnessed the return of the drugs by entering her user number and password to confirm Bode’s actions. However, when the pharmacy staff checked the Sure-Med return compartment the next day, no Demerol ampule was found. Vargas told her supervisor and the head of the anesthesiology department that Bode returned Fentanyl and Vargas claimed to have alerted Bode to correct the information in the Sure-Med system. However, Vargas told the pharmacy chief she did not see, or did not know, what Bode returned. On March 21, 2003, Popoola and the Hospital’s Chief of Staff, Lowell Theard, sent a joint letter stating Bode was summarily suspended until further notice due to the issues surrounding the return of controlled medications on March 18, 2003. They noted that there was no evidence patient care had been adversely affected, and did not consider the suspension to be a disciplinary action. They stated that the surgery department would convene to determine a course of action. On March 25, 2003, the surgery department’s peer review subcommittee held an emergency meeting. Bode appeared and described her actions regarding the missing drug. She noted she had never had any problems with dispensing or returning controlled substances. The peer review subcommittee was unable to reach a decision about the discrepancy. They agreed Bode would remain on summary suspension while the Chief of Anesthesiology reviewed reports and provided findings to the surgery department.

4 The Chief of Anesthesiology could not determine an explanation for the missing drug. On March 26, 2003, the surgery department recommended an extension of Bode’s suspension until March 30, 2003, which was the date her temporary privileges expired. Her privileges would be allowed to expire and not be renewed until the matter of the missing drug was satisfactorily resolved.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Angelica Textile Services Inc. v. Park
220 Cal. App. 4th 495 (California Court of Appeal, 2013)
Dvorin v. Appellate Department
542 P.2d 1363 (California Supreme Court, 1975)
Fox v. Good Samaritan L.P.
801 F. Supp. 2d 883 (N.D. California, 2010)
Bode v. Los Angeles Metropolitan Medical Center
174 Cal. App. 4th 1224 (California Court of Appeal, 2009)
Smith v. Selma Community Hospital
188 Cal. App. 4th 1 (California Court of Appeal, 2010)
Fahlen v. Sutter Central Valley Hospitals
318 P.3d 833 (California Supreme Court, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Bode v. Los Angeles Doctors Hospital CA2/5, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bode-v-los-angeles-doctors-hospital-ca25-calctapp-2014.